Merce Bonastre
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 27, 2022
Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 20, 2021
Globus pallidus, but not entopeduncular nucleus, 6-OHDA-induced lesion attenuates L-Dopa-induced dyskinesia in the rat model of Parkinson's disease.
Journal: Pharmacology, biochemistry, and behavior
Published: June 02, 2020
Lack of correlation between dyskinesia and pallidal serotonin transporter expression-induced by L-Dopa and Pramipexole in hemiparkinsonian rats.
Journal: Pharmacology, biochemistry, and behavior
Published: February 21, 2020
Recovery of Olfactory Function After Excitotoxic Lesion of the Olfactory Bulbs Is Associated with Increases in Bulbar SIRT1 and SIRT4 Expressions.
Journal: Molecular neurobiology
Published: August 27, 2018
In vivo evaluation of the dopaminergic neurotransmission system using [123I]FP-CIT SPECT in 6-OHDA lesioned rats.
Journal: Contrast media & molecular imaging
Published: December 18, 2013
Early L-dopa, but not pramipexole, restores basal ganglia activity in partially 6-OHDA-lesioned rats.
Journal: Neurobiology of disease
Published: November 12, 2013
Subthalamic 6-OHDA-induced lesion attenuates levodopa-induced dyskinesias in the rat model of Parkinson's disease.
Journal: Experimental neurology
Published: August 10, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026